Market Overview

9 Biggest Mid-Day Gainers For Friday

  • West Marine, Inc. (NASDAQ: WMAR) shares climbed 33 percent to $12.83 after the company agreed be acquired by Monomoy Capital Partners for $12.97 per share.
  • Quinpario Acquisition Corp 2 (NASDAQ: QPAC) shares gained 22.5 percent to $9.38.
  • Albireo Pharma, Inc. (NASDAQ: ALBO) shares rose 13.8 percent to $20.19. Wedbush initiated coverage on Albireo Pharma with an Outperform rating and a $58.00 price target.
  • Parkway Inc (NYSE: PKY) shares climbed 12.4 percent to $22.91. Canada Pension Plan Investment Board announced plans to buy Parkway for $23.05 per share.
  • Obseva SA (NASDAQ: OBSV) shares rose 10.7 percent to $8.30.
  • Hain Celestial Group Inc (NASDAQ: HAIN) shares gained 10 percent to $39.34. Engaged Capital disclosed a 9.9 percent stake in Hain Celestial, according to 13D filing.
  • Allied Healthcare Products Inc (NASDAQ: AHPI) shares climbed 9.2 percent to $2.73.
  • Semiconductor Manufacturing Int'l (ADR) (NYSE: SMI) shares rose 8.6 percent to $5.69.
  • Nike Inc (NYSE: NKE) shares gained 8.3 percent to $57.58 after the company reported stronger-than-expected earnings for its fourth quarter.

Posted-In: Mid-Day GainersNews Intraday Update Markets Analyst Ratings Movers


Related Articles (AHPI + ALBO)

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

A Long-Term View On The E-Commerce Vs. Parcel Debate

Bayer-Funded Study Blows Up In Its Face After Scientists Find Its Pesticide Is Killing Bees